labetalol has been researched along with Marfan Syndrome, Type I in 2 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This patient with Marfan syndrome whose case is reported herein presented with chest pain, hypertensive crisis, and aortic insufficiency; labetalol was used successfully to treat the acute hypertensive crisis and magnetic resonance imaging (MRI) was used to differentiate between aortic dissection and an expanding aortic aneurysm." | 7.68 | Labetalol and MRI as initial medical and diagnostic modalities in a marfanoid patient with expanding ascending aortic aneurysm. ( Baciewicz, FA; Grubb, B; Laden, N, 1990) |
| " This patient with Marfan syndrome whose case is reported herein presented with chest pain, hypertensive crisis, and aortic insufficiency; labetalol was used successfully to treat the acute hypertensive crisis and magnetic resonance imaging (MRI) was used to differentiate between aortic dissection and an expanding aortic aneurysm." | 3.68 | Labetalol and MRI as initial medical and diagnostic modalities in a marfanoid patient with expanding ascending aortic aneurysm. ( Baciewicz, FA; Grubb, B; Laden, N, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meijboom, LJ | 1 |
| Westerhof, BE | 1 |
| Nollen, GJ | 1 |
| Spaan, JA | 1 |
| de Mol, BA | 1 |
| Jacobs, MJ | 1 |
| Mulder, BJ | 1 |
| Laden, N | 1 |
| Baciewicz, FA | 1 |
| Grubb, B | 1 |
2 other studies available for labetalol and Marfan Syndrome, Type I
| Article | Year |
|---|---|
Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement.
Topics: Adrenergic beta-Antagonists; Adult; Aorta; Atenolol; Blood Pressure; Blood Vessel Prosthesis Implant | 2004 |
Labetalol and MRI as initial medical and diagnostic modalities in a marfanoid patient with expanding ascending aortic aneurysm.
Topics: Acute Disease; Aorta; Aortic Aneurysm; Aortic Dissection; Humans; Hypertension; Labetalol; Magnetic | 1990 |